Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
What’s Your Call?
Collective community sentiment on Mono Pharmacare Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
2 users have voted
Market Depth
How many stocks are available to buy or sell and at what prices.
Buy Order Quantity
NaN%
Sell Order Quantity
NaN%
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Bid Price
Qty
0.00
0
0.00
0
0.00
0
0.00
0
0.00
0
Bid Total
0
Option Chain
Analyzes market sentiment, predicts Mono Pharmacare Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Mono Pharmacare - Structural Digital Database
-
Mono Pharmacare - Updates
-
Mono Pharmacare - Outcome of Board Meeting
-
Mono Pharmacare - Board Meeting Intimation
-
Mono Pharmacare - Board Meeting Intimation
-
Mono Pharmacare has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2025
-
Mono Pharmacare - Structural Digital Database
-
Mono Pharmacare - Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
-
Mono Pharmacare - Certificate under SEBI (Depositories and Participants) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Mono Pharmacare Ltd stock
| Name | March-25 | March-24 | March-23 | March-22 | March-21 |
|---|---|---|---|---|---|
| Assets | 54.892 | 41.3789 | 25.9045 | 10.715 | 9.7761 |
| Liabilities | 54.892 | 41.3789 | 25.9045 | 10.715 | 9.7761 |
| Equity | 17.6686 | 17.6686 | 12.3686 | 4.2757 | 3.6958 |
| Gross Profit | 2.5638 | 2.4518 | 0.8689 | 1.2816 | 0.8469 |
| Net Profit | 3.0902 | 2.4424 | 0.5418 | 0.3509 | 0.0951 |
| Cash From Operating Activities | 1.2934 | -10.3164 | -13.4917 | 0.2397 | -0.7836 |
| NPM(%) | 3.73 | 3.45 | 3.89 | 0.94 | 0.33 |
| Revenue | 82.6408 | 70.7199 | 13.9161 | 36.983 | 28.2661 |
| Expenses | 80.077 | 68.2681 | 13.0472 | 35.7014 | 27.4192 |
| ROE(%) | 10.17 | 8.04 | 1.78 | 1.15 | 0.31 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Mono Pharmacare Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 905.60 | 0.25 | 30.05 | 0.00 | 301.39 | 0.55 |
| Lotus Eye Hospital and Institute Ltd | 73.05 | -1.14 | 208.71 | 0.00 | 3.55 | 0.00 |
| Vaishali Pharma Ltd | 12.76 | -0.23 | 212.67 | 0.00 | 3.13 | 0.00 |
| Astec Lifesciences Ltd | 893.55 | -0.53 | 0.00 | 0.00 | -601.21 | 0.00 |
Company Info
The company was originally formed as a partnership firm in the name and style of "M/s. Mono Chemist" through partnership deed dated May 06, 1994. Promoters of the company Panilam Lakhatariya and Supal Lakhatariya joined the partnership firm on May 10, 2018, as partners of the firm. Further, the Promoters acquired 100% ownership of the partnership firm on July 25, 2019. Further, new partners i.e. Shivlal Gandalal Lakhatariya, Shardaben Shivlal Lakhatariya, Shivam Parag Chauhan, Archit Suhasbhai Shah and Pallaviben Suhasbhai Shah were added pursuant to deed of admission dated June 18, 2022. The partnership firm was then converted into Public Limited company under part I (Chapter XXI) of the Companies Act, 2013 in the name and style of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad. The corporate identification number of the Company is U24304GJ2022PLC136193.Key Events and Milestones:1994- Incorporated Partnership firm in style of `M/s Mono Chemist'2018- Panilam and Supal Lakhatariya are introduced as Incoming partners of Partnership firm.2019- Revenue experienced a growth of more than 2x times after the introduction of the promoters.2022- Conversion of the company from Partnership Firm to Public Limited Company.- Takeover of the business of DLS Export (Proprietorship firm of Panilam Lakhatariya)2023- Takeover of the business of Ahmedabad Medical Corporation and Supal Distributors LLP.
The company was originally formed as a partnership firm in the name and style of "M/s. Mono Chemist" through partnership deed dated May 06, 1994. Promoters of the company Panilam Lakhatariya and Supal Lakhatariya joined the partnership firm on May 10, 2018, as partners of the firm. Further, the Promoters acquired 100% ownership of the partnership firm on July 25, 2019. Further, new partners i.e. Shivlal Gandalal Lakhatariya, Shardaben Shivlal Lakhatariya, Shivam Parag Chauhan, Archit Suhasbhai Shah and Pallaviben Suhasbhai Shah were added pursuant to deed of admission dated June 18, 2022. The partnership firm was then converted into Public Limited company under part I (Chapter XXI) of the Companies Act, 2013 in the name and style of Mono Pharmacare Limited vide Certificate of Incorporation dated October 17, 2022, was issued by the Registrar of Companies, Ahmedabad. The corporate identification number of the Company is U24304GJ2022PLC136193.Key Events and Milestones:1994- Incorporated Partnership firm in style of `M/s Mono Chemist'2018- Panilam and Supal Lakhatariya are introduced as Incoming partners of Partnership firm.2019- Revenue experienced a growth of more than 2x times after the introduction of the promoters.2022- Conversion of the company from Partnership Firm to Public Limited Company.- Takeover of the business of DLS Export (Proprietorship firm of Panilam Lakhatariya)2023- Takeover of the business of Ahmedabad Medical Corporation and Supal Distributors LLP.
Read More
Parent Organisation
Mono Pharmacare Ltd.
Founded
06/05/1994
Managing Director
Mr.Panilam Lakhatariya
NSE Symbol
MONOPHARMASM
FAQ
The current price of Mono Pharmacare Ltd is
The 52-week high for Mono Pharmacare Ltd is
The market capitalization of Mono Pharmacare Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Mono Pharmacare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Mono Pharmacare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Mono Pharmacare Ltd shares.
The CEO of Mono Pharmacare Ltd is Mr.Panilam Lakhatariya, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
